BOSU
BOSU Surveillance Study Bursary
With the kind support from The Red Trust and the Ross Foundation, the BOSU is once again offering three research bursaries of £6000 to support ophthalmologists in training to undertake an epidemiological study of a rare eye condition through the British Ophthalmological Surveillance Unit or the Scottish Ophthalmological Surveillance Unit. The objective for these awards
BOSU report shows patients losing sight to follow-up appointment delays
The Royal College of Ophthalmologists publishes a surveillance report of patients losing vision due to delays in treatment and follow-up appointments The research, conducted through the British Ophthalmological Surveillance Unit (BOSU), found patients suffering permanent and severe visual loss due to health service initiated delays1. The research involving all UK consultant ophthalmologists, showed that up to 22
The Way Forward – a resource for collaborative working to review and redesign eye care services in the UK
The Royal College of Ophthalmologists publishes The Way Forward for the review and redesign of eye care services. The increasing demand for hospital eye services is not being met and continues to grow, currently ophthalmology deals with nearly 10% of all out-patient appointments and performing 6% of the overall surgery in the UK. The Way
The BOSU Surveillance Study Bursary for an ophthalmologist in Training 2016
With the kind support from The Red Trust and the Ross Foundation the BOSU is once again offering three research bursaries of £6000 to support ophthalmologists in training to undertake an epidemiological study of a rare eye condition through the British Ophthalmological Surveillance Unit or the Scottish Ophthalmological Surveillance Unit. The RED Trust BOSU Bursary–
Response to NICE Guidelines Diabetes (type 1 and type 2) in children and young people 2015
The Royal College of Ophthalmologists welcomes the update Guidelines from NICE on Diabetes (type 1 and type 2) in children and young people 2015 The College is pleased that the updated Guidelines recognise that although background retinopathy (BDR) is not part of the screening target, this condition is diagnosed during the screening, and the results